HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis.
HIV-1
Web of Science Core Collection
bibliometric analysis
genetic diversity
vaccine
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
31 12 2022
31 12 2022
Historique:
pubmed:
13
1
2022
medline:
5
4
2022
entrez:
12
1
2022
Statut:
ppublish
Résumé
Despite recent advances in human immunodeficiency virus-1 (HIV-1) prevention, a fast, safe, and effective vaccine will probably be necessary to end the HIV/AIDS pandemic. This study was conducted to evaluate global research trends and map the key bibliometric indices in HIV-1 genetic diversity from 1998 to 2021. A comprehensive online search was conducted in the Web of Science Core Collection database to retrieve published literature on HIV-1 genetic diversity. Key bibliometric indicators were calculated and evaluated using HistCite A total of 2,060 documents written by 9,201 authors and published in 250 journals were included in the final analysis. Year 2012 was the most productive year with 121 (5.87%) publications. The most prolific author was Shao Yiming (n = 74, 3.59%) from Chinese Center for Disease Control and Prevention. The United States of America was the highly contributing and influential country (n = 681, 33.05%). This study provides global research trends and detailed information on HIV-1 genetic diversity. The amount of scientific literature on HIV-1 genetic diversity research has rapidly increased in the last two decades. The maximum number of articles on HIV-1 genetic diversity was published in developed countries; therefore, a scientific research collaboration among researchers and institutes in low-income countries should be promoted and supported.
Sections du résumé
BACKGROUND
Despite recent advances in human immunodeficiency virus-1 (HIV-1) prevention, a fast, safe, and effective vaccine will probably be necessary to end the HIV/AIDS pandemic. This study was conducted to evaluate global research trends and map the key bibliometric indices in HIV-1 genetic diversity from 1998 to 2021.
METHODS
A comprehensive online search was conducted in the Web of Science Core Collection database to retrieve published literature on HIV-1 genetic diversity. Key bibliometric indicators were calculated and evaluated using HistCite
RESULTS
A total of 2,060 documents written by 9,201 authors and published in 250 journals were included in the final analysis. Year 2012 was the most productive year with 121 (5.87%) publications. The most prolific author was Shao Yiming (n = 74, 3.59%) from Chinese Center for Disease Control and Prevention. The United States of America was the highly contributing and influential country (n = 681, 33.05%).
CONCLUSION
This study provides global research trends and detailed information on HIV-1 genetic diversity. The amount of scientific literature on HIV-1 genetic diversity research has rapidly increased in the last two decades. The maximum number of articles on HIV-1 genetic diversity was published in developed countries; therefore, a scientific research collaboration among researchers and institutes in low-income countries should be promoted and supported.
Identifiants
pubmed: 35016590
doi: 10.1080/21645515.2021.2014733
pmc: PMC8973384
doi:
Substances chimiques
AIDS Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2014733Références
Hum Vaccin Immunother. 2021 Sep 2;17(9):3169-3177
pubmed: 33945433
Lancet Infect Dis. 2019 Feb;19(2):143-155
pubmed: 30509777
Immunol Rev. 2017 Jan;275(1):230-244
pubmed: 28133800
Biomed Res Int. 2020 Oct 16;2020:5737893
pubmed: 33123578
Emerg Infect Dis. 2021 Jun;27(6):1553-1560
pubmed: 34013858
Scientometrics. 2010 Aug;84(2):523-538
pubmed: 20585380
J Infect. 2021 Aug;83(2):237-279
pubmed: 34010622
AIDS Res Hum Retroviruses. 2020 Oct;36(10):875-880
pubmed: 32640836
Pharmacotherapy. 2015 Jun;35(6):551-9
pubmed: 25940769
Science. 2000 Jun 9;288(5472):1789-96
pubmed: 10846155
Br J Haematol. 2016 Jun;173(6):918-26
pubmed: 26970408
AIDS Res Hum Retroviruses. 2014 Jun;30(6):598-602
pubmed: 24279591
Hum Vaccin Immunother. 2021 Sep 2;17(9):3221-3229
pubmed: 33945397
Front Pediatr. 2021 Oct 28;9:762531
pubmed: 34778152
Curr Opin HIV AIDS. 2019 May;14(3):153-160
pubmed: 30882484
Transfus Med Hemother. 2016 May;43(3):203-22
pubmed: 27403093
BMC Infect Dis. 2008 Feb 26;8:19
pubmed: 18302752
Front Microbiol. 2021 Jul 15;12:690647
pubmed: 34335516
J Virol. 2020 Dec 22;95(2):
pubmed: 33087461
Trends Mol Med. 2012 Mar;18(3):182-92
pubmed: 22240486
AIDS Res Hum Retroviruses. 2017 Oct;33(10):1056-1060
pubmed: 28557610
Hum Vaccin Immunother. 2021 Aug 3;17(8):2367-2372
pubmed: 33687303
Expert Rev Vaccines. 2005 Aug;4(4):513-20
pubmed: 16117708
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1343-52
pubmed: 25733890
Psychother Psychosom. 2021;90(6):425-430
pubmed: 33957635
Science. 2000 Apr 7;288(5463):55-6
pubmed: 10766634
Biomed Res Int. 2020 Sep 3;2020:5476567
pubmed: 32964036
AIDS Res Hum Retroviruses. 2014 Apr;30(4):380-3
pubmed: 24164474
J Virol. 2005 Aug;79(16):10108-25
pubmed: 16051804
Bull Med Libr Assoc. 2000 Jan;88(1):56-61
pubmed: 10658964
BMC Med Inform Decis Mak. 2021 May 3;21(1):144
pubmed: 33941172
AIDS Res Hum Retroviruses. 2014 Apr;30(4):389-93
pubmed: 24205972
Scientometrics. 2018;115(1):1-20
pubmed: 29527070
Lancet Infect Dis. 2002 Aug;2(8):461-71
pubmed: 12150845